Last Updated: November 4, 2026
Ketamine Therapy in Massachusetts
Mindbloom provides evidence-based ketamine therapy to Massachusetts residents through a clinician-led telehealth program. Treatment is prescribed and supervised by a Massachusetts-licensed psychiatric clinician and delivered in the comfort of your home. Mindbloom offers two medication options: sublingual ketamine tablets and subcutaneous ketamine injections, making it the only at-home provider offering subcutaneous ketamine alongside sublingual tablets.

Key takeaways
- Statewide telehealth access: Mindbloom serves residents across all of Massachusetts via telehealth, including Boston, Worcester, Springfield, Cambridge, Lowell, and communities throughout Cape Cod, the Berkshires, Western Massachusetts, the South Shore, and the North Shore, with no in-person clinic visit required.
- Published outcomes: Mindbloom's published research shows that in Mindbloom's 2022 peer-reviewed study of 1,247 clients using sublingual tablets, 89% reported improvement in depression or anxiety after four sessions 1; in a peer-reviewed study of subcutaneous injections (Parks et al. 2026, J Med Internet Res; n=623 with PTSD), 84.6% of PTSD clients saw clinically meaningful improvement by the end of the six-session course, with a 76.7% response rate 3; and 76.8% of clients who completed treatment met criteria for sleep response. 4
- Affordable pricing: Session costs for new clients range from $165-$215 depending on the program selected, approximately 60-70% less than in-clinic IV ketamine infusions in Massachusetts, and are HSA/FSA eligible.
How Mindbloom Works in Massachusetts
1. Complete an Online Assessment
Your journey begins with a comprehensive medical intake that gathers your health history, current medications, and treatment goals. A Massachusetts-licensed psychiatric clinician reviews your information to determine whether ketamine therapy is appropriate for your situation. This step is designed to screen for contraindications and ensure that treatment is both safe and clinically indicated.
2. Meet with a Massachusetts-Licensed Clinician
You'll have a video consultation with a psychiatric clinician licensed to practice in Massachusetts. During this appointment, your clinician screens for contraindications, discusses your mental health history, answers your questions, and, if appropriate, develops a personalized treatment plan. This includes establishing your dosing protocol.
3. Prepare for Your At-Home Sessions
Once your treatment plan is set, Mindbloom ships your Bloombox, an experience toolkit that includes everything you need for your sessions at home. You'll also arrange for a peer treatment monitor to be present during each session. This is a friend or family member you choose who stays nearby throughout the experience, offering support. You'll receive access to the Mindbloom app, which contains session preparation materials and guided content.
4. Conduct Sessions at Home
Right before your first session, you'll meet virtually with your guide to set intentions. Every Mindbloom client works with a dedicated guide, a trained psychedelic integration specialist who helps them prepare for each session and turn what comes up into lasting change. Guides are part of a care team led by licensed clinicians, who handle evaluation, prescribing, and dosing, and guides share safety and progress updates with them. During each session, you'll use the Mindbloom app to access one of over 150 curated soundscapes designed to support the therapeutic experience. Sessions typically last 60 to 90 minutes. Your peer treatment monitor remains present in your home throughout. Your Mindbloom guide walks them through the process and gives them the information and resources they need to feel comfortable in the role. They stay in a nearby room, checking in about every 15 minutes.
5. Integrate and Build on Your Progress
Between sessions, your Mindbloom guide provides 1:1 coaching and is available via unlimited messaging to help you process your experiences and translate insights into lasting change. You'll also have access to daily Integration Circles, live group sessions facilitated by trained practitioners, along with journaling prompts, breathing exercises, and other app-based tools designed to deepen the therapeutic benefit of each session.
Mental Health in Massachusetts
Massachusetts ranked 6th overall in Mental Health America's 2025 report⁵, and the state has 813.9 mental health providers per 100,000 residents, ranking 2nd nationally.⁶ The state's suicide rate of 9.4 per 100,000 is among the lowest in the country.⁷ However, those top-line numbers mask persistent geographic access challenges. Provider availability remains concentrated in the Boston metro area, and the state still has more than 50 federally designated mental health professional shortage areas⁸, leaving communities throughout Western Massachusetts, Cape Cod, the Berkshires, the South Shore, and the North Shore underserved. For Massachusetts residents living with depression, anxiety, PTSD, or related conditions like OCD, burnout, grief, and chronic pain, telehealth-based treatment offers a way to access specialized care without long wait times or hours of travel.
Mindbloom's Published Outcomes for Depression, Anxiety, and PTSD
Mindbloom's clinical outcomes for depression and anxiety with sublingual tablets are drawn from two peer-reviewed studies published in the Journal of Affective Disorders 1,2. PTSD outcomes come from a third peer-reviewed study, of subcutaneous injections, published in the Journal of Medical Internet Research 3. Together, these three peer-reviewed studies form the largest published evidence base in at-home ketamine therapy. All data reflects outcomes from Mindbloom clients treated under Mindbloom's clinical protocol.
Depression
In Mindbloom's 2022 peer-reviewed study of 1,247 clients using sublingual tablets, 89% reported improvement in depression or anxiety after four sessions. 1 In the largest published study of at-home ketamine therapy, which followed 11,441 patients using sublingual tablets, 56.4% met criteria for depression response and 28.1% reached remission. 2
Anxiety
In the same 11,441-patient study, among the 7,776 patients with a baseline anxiety score, 62.2% achieved clinically significant change in anxiety symptoms, with 56.1% meeting criteria for anxiety response and 28.8% reaching remission. 2
PTSD
In a peer-reviewed study of Mindbloom clients using subcutaneous injections, by the end of the six-session course, 84.6% saw clinically meaningful improvement, with a 76.7% response rate and 56.7% remission rate. 3 Mindbloom is the only at-home provider with peer-reviewed PTSD outcomes.
Sleep
In a real-world analysis of 13,963 adults with moderate-to-severe sleep disturbance, 76.8% of clients who completed treatment met criteria for sleep response, and only 2.5% reported worsened sleep. 4
Safety
Mindbloom has completed more than 900,000 sessions as of October 2026. In its published studies, side effects were reported by about 4 to 5% of participants per check-in (sublingual tablets). 1,2 The most commonly reported effects, including nausea, dizziness, and transient dissociation, are typically mild and resolve within the post-session window.
Safety Protocols
Mindbloom's clinical program is built around multiple layers of medical oversight:
- Medical screening: Before treatment begins, your clinician conducts a thorough evaluation for contraindications, including cardiovascular screening with blood pressure and heart rate assessment.
- Session monitoring: A peer treatment monitor is required to be physically present during every session, providing real-time support and an additional layer of safety.
- Follow-up care: Your clinician monitors your response to treatment and adjusts dosing or protocol as needed. Tolerability is assessed on an ongoing basis throughout your program.
Where Mindbloom Serves in Massachusetts
Mindbloom serves Massachusetts residents statewide through its telehealth platform, making evidence-based ketamine therapy available to communities that have historically had limited access to specialized mental health treatment. In-clinic ketamine therapy options in Massachusetts are concentrated in the Boston area, leaving many communities throughout Western Massachusetts, Cape Cod, the Berkshires, the South Shore, and the North Shore underserved. Mindbloom's program is accessible from anywhere in Massachusetts with an internet connection.
Mindbloom serves residents in and around: Boston, Worcester, Springfield, Cambridge, Lowell, Brockton, New Bedford, Fall River, Quincy, Newton, Framingham, Somerville, Lynn, Lawrence, Haverhill, Plymouth, and throughout the state, including Cape Cod, the Berkshires, Western Massachusetts, the South Shore, and the North Shore.
Mindbloom is not limited to these areas. Any Massachusetts resident with a valid Massachusetts address can access the program.
How Ketamine Therapy Options Compare in Massachusetts
Several forms of ketamine therapy are available in Massachusetts, each with different settings, costs, and accessibility:
- IV ketamine infusion: Administered intravenously at an in-clinic facility with on-site medical staff. Typically costs $400 to $800+ per infusion and is limited to major metro areas.
- IM ketamine injection: Administered intramuscularly at an in-clinic facility with on-site medical staff. Typically costs $300-$600 per injection and is limited to major metro areas.
- Spravato (esketamine): An FDA-approved nasal spray administered in a certified healthcare setting with a required 2-hour post-dose observation period. Covered by some insurance plans; copays vary.
- Mindbloom: Sublingual tablets or subcutaneous injections, taken at home with a peer treatment monitor present. Costs $165-$215 per session and is available to residents statewide via telehealth.
Ketamine is a Schedule III controlled substance that has been FDA-approved as an anesthetic since 1970. Its use for depression, anxiety, and PTSD is considered off-label, meaning the medication is being prescribed for a condition outside its original FDA indication. This is common across medicine: about 21% of U.S. office-based prescriptions are written for off-label uses (Radley et al., 2006). 9 Off-label prescribing is a well-established, routine practice in medicine. Ketamine's use for mental health conditions is supported by a robust body of clinical research on how ketamine works at the neurological level.
How Much Ketamine Therapy Costs in Massachusetts
In-clinic IV ketamine infusions in Massachusetts typically cost $400 to $800+ per session, while IM injections range from $300 to $600. Spravato (esketamine) may be covered by some insurance plans, with copays varying. Mindbloom sessions cost $165-$215 depending on the program selected, representing savings of approximately 60-70% compared to in-clinic IV infusion options. Mindbloom sessions are HSA and FSA eligible, and Mindbloom provides superbills that you can submit to your insurance provider for potential out-of-network reimbursement. Learn more about insurance and payment options.
Why Massachusetts Residents Choose Mindbloom
- Peer-reviewed research: Mindbloom's outcomes are published in peer-reviewed journals, meaning the data comes from the actual program you'd enroll in, not a separate clinical trial. Research was conducted in collaboration with academic and clinical institutions.
- Scale and experience: Mindbloom has completed more than 900,000 sessions, backed by the largest published evidence base in at-home ketamine therapy.
- Comprehensive care model: Treatment extends well beyond the medication itself. Your program includes 1:1 guide coaching, unlimited messaging, daily Integration Circles, over 150 curated soundscapes, and app-based integration tools.
- Statewide access: No in-person clinic visits required. Mindbloom's telehealth model reaches every corner of Massachusetts, from Boston to Western Massachusetts to Cape Cod and the Berkshires.
- Affordability: At $165-$215 per session with HSA/FSA eligibility and superbill support, Mindbloom makes ketamine therapy financially accessible.
How to Choose a Ketamine Therapy Provider in Massachusetts
When evaluating ketamine therapy providers, whether in-clinic or telehealth, consider the following:
- Clinical oversight: Is treatment prescribed and monitored by a licensed psychiatric clinician? Is there a structured intake process with contraindication screening?
- Published outcomes: Does the provider publish clinical outcomes from their own patient population? Is the data peer-reviewed?
- Safety protocols: What monitoring is required during sessions? What happens if you experience a side effect or adverse reaction?
- Integration support: Does the program offer support between sessions, such as coaching, integration tools, and group sessions, or is it medication-only?
- Transparency: Is pricing clear? Are the clinician's credentials and the program's clinical protocol publicly available?
Frequently asked questions
Is ketamine therapy available in Massachusetts?
Yes. Ketamine therapy is available in Massachusetts through both in-clinic providers (IV and IM) and telehealth-based at-home programs like Mindbloom. Mindbloom serves all Massachusetts residents statewide.
Do I need to visit a clinic for ketamine therapy?
Not with Mindbloom. Treatment is prescribed via telehealth and conducted at home. You'll meet with a Massachusetts-licensed clinician by video, and sessions take place in your own space with a peer treatment monitor present.
How quickly can ketamine therapy work?
Many clients report noticing changes within the first few sessions. However, individual responses vary, and your clinician will work with you to assess progress and adjust treatment as needed.
What conditions does Mindbloom treat?
Mindbloom's program is designed for adults experiencing depression, anxiety, and PTSD. Ketamine therapy may also be valuable for people dealing with related conditions like chronic pain, OCD, burnout, and grief, many of which overlap with anxiety and depression. Your clinician determines whether ketamine therapy is appropriate during the intake evaluation.
Is ketamine therapy safe?
Ketamine has been used in clinical settings since 1970 and has a well-established safety profile. Mindbloom's program includes medical screening, required peer treatment monitor presence during sessions, and ongoing clinician oversight. Mindbloom has completed more than 900,000 sessions. In its published studies, side effects were reported by about 4 to 5% of participants per check-in with sublingual tablets.
How much does ketamine therapy cost in Massachusetts?
Mindbloom sessions cost $165-$215 depending on the program selected. Treatment is HSA and FSA eligible. Most insurance plans do not cover off-label ketamine therapy directly, but Mindbloom provides superbills that you can submit for potential out-of-network reimbursement.
How does Mindbloom compare to visiting a ketamine clinic in Massachusetts?
In-clinic options (IV infusion, IM injection, Spravato) require travel to a facility, which in Massachusetts typically means a clinic in the Boston area. For residents in Western Massachusetts, Cape Cod, the Berkshires, or rural parts of the state, that can mean hours of driving. Mindbloom delivers treatment to your home via telehealth and includes integration support (guide coaching, Integration Circles, app tools) that many clinics do not provide, at approximately 60-70% lower cost.

Mindbloom Treatment
See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.







